Another Triple M host has sensationally stepped down after Marty Sheargold was axed from the station for his comments about the Matildas last week.

Learn more about whether Haleon plc or Intra-Cellular Therapies, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Haleon Sri Lanka formerly known as GlaxoSmithKline Healthcare; the first multinational pharmaceutical manufacturing organization in Sri Lanka, which commenced manufacturing in 1956 with the flagship ...

Haleon plc (NYSE: HLN) Q4 2024 Earnings Call Transcript February 27, 2025 Haleon plc misses on earnings expectations.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

We believe Haleon is in fine financial health. In preparation of separating from GSK, its former parent, Haleon took on roughly GBP 10 billion in debt and post spinning out the company in July 2022 it ...

Boss Mark Read (pictured) said that although revenues were hit by weaker client discretionary spending, growth of 2% was seen ...

Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains ...

Q4 2024 Earnings Conference Call February 27, 2025 4:00 AM ETCompany ParticipantsJo Russell - Head-Investor RelationsBrian McNamara ...

British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted to the second half ...

HALEON PLC (LON:HLN) shares slid 3% in London on Thursday after the Sensodyne toothpaste maker said its revenue growth for 2025 would be weighted toward the second half of the year.

Haleon disappointed investors after the Sensodyne toothpaste maker said 2025 revenue growth would be weighted to the second half of the year.